CytomX Therapeutics (CTMX) vs Electra Therapeutics (ETRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Electra Therapeutics is the larger company by market cap ($571.8 million vs $537.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTMX | ETRA |
|---|---|---|
| Share price | $2.47 | $9.11 |
| Market cap | $537.12M | $571.81M |
| 1-day change | -3.33% | -0.55% |
| YTD return | -40.14% | — |
| 1-year return | -23.42% | — |
| 5-year return | -50.39% | — |
| EPS (TTM) | $-0.51 | $-2.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.21 | $15.50 |
| 52-week low | $2.43 | $8.63 |
| Distance from 52-week high | -69.98% | -41.23% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +396.96% | — |
| Average volume | 3.34M | 948.89K |
| Shares outstanding | 217.90M | 62.77M |
| Employees | 69 | 46 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CytomX Therapeutics
CTMX stock →CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenvironment.
Health Care · Biotechnology: Pharmaceutical Preparations · 69 employees
About Electra Therapeutics
ETRA stock →Electra Therapeutics, Inc. is a clinical-stage biotechnology company.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 46 employees
CTMX vs ETRA FAQ
Which is bigger, CytomX Therapeutics or Electra Therapeutics?
Electra Therapeutics (ETRA) is larger, with a market capitalization of $571.81M compared with $537.12M for CytomX Therapeutics (CTMX).
Are CytomX Therapeutics and Electra Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for CytomX Therapeutics and Biotechnology: Biological Products (No Diagnostic Substances) for Electra Therapeutics.